Rang	Name	Position
1	Dr. Gilmore O'Neill M.D.	President, CEO & Director
2	Ms. Amy Parison	Senior VP & CFO
3	Dr. Linda C. Burkly Ph.D.	Executive VP & Chief Scientific Officer
4	Dr. Feng Zhang Ph.D.	Co-Founder & Scientific Advisory Board Member
5	Dr. George McDonald Church Ph.D.	Co-Founder & Scientific Advisory Board Member
6	Mr. Gregory Whitehead	Executive VP and Chief Technical & Quality Officer
7	Mr. Damien Grierson J.D.	Senior VP, General Counsel & Corporate Secretary
8	Mr. Tom Love	Vice President of People
9	Mr. Frank Panaccio	Senior VP & Chief Business Officer
10	Ms. Brieana Buckley	Senior Vice President of Development and Program Leadership

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	TCG Crossover Management, LLC	7,23%	30,00 Mio. USD
2	BlackRock Inc	6,03%	25,01 Mio. USD
3	Paradigm Biocapital Advisors LP	3,64%	15,08 Mio. USD
4	Vanguard Capital Management, LLC	2,74%	11,35 Mio. USD
5	Renaissance Technologies Corp	2,59%	10,73 Mio. USD
6	Opaleye Management Inc	2,51%	10,43 Mio. USD
7	Vivo Capital, LLC	2,31%	9,60 Mio. USD
8	Vanguard Portfolio Management, LLC	2,05%	8,50 Mio. USD
9	GordonMD Global Investments LP	2,04%	8,44 Mio. USD
10	Geode Capital Management, LLC	1,51%	6,24 Mio. USD
11	Logos Global Management LP	1,45%	6,00 Mio. USD
12	State Street Corp	1,35%	5,61 Mio. USD
13	Nuveen, LLC	1,29%	5,34 Mio. USD
14	JPMorgan Chase & Co	1,27%	5,26 Mio. USD
15	D. E. Shaw & Co LP	1,24%	5,13 Mio. USD
16	Acadian Asset Management LLC	0,95%	3,94 Mio. USD
17	AQR Capital Management LLC	0,89%	3,70 Mio. USD
18	Two Sigma Investments LLC	0,87%	3,60 Mio. USD
19	Kennedy Capital Management Inc	0,67%	2,79 Mio. USD
20	Charles Schwab Investment Management Inc	0,56%	2,33 Mio. USD